Is Assessing the Presence of NASH by Liver Histology or Surrogate Markers Always Advisable?

@inproceedings{Tarantino2013IsAT,
  title={Is Assessing the Presence of NASH by Liver Histology or Surrogate Markers Always Advisable?},
  author={Giovanni Tarantino},
  booktitle={Hepatitis monthly},
  year={2013}
}
Implication for health policy/practice/research/medical education: Suggestions to improve NAFLD/NASH management by physicians and health operators. which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. To gather objective evidence for the effectiveness of their interventions, should responsible clinicians rely on the necessity to better characterize patients with nonal-coholic fatty liver disease as being affected by the… CONTINUE READING